CareFusion Launches Next-Generation Clinical Diagnostics Software for Jaeger(TM) and SensorMedics(R) Product Lines

By Carefusion, PRNE
Sunday, September 19, 2010

HOCHBERG, Germany, September 20, 2010 - CareFusion (NYSE: CFN), a leading, global medical device company, today
announced the commercial release of SentrySuite(TM), the next-generation
clinical diagnostics software for the Jaeger(TM) and SensorMedics(R)
Pulmonary Diagnostics and CardioPulmonary Diagnostics instruments.

SentrySuite is an innovative set of software applications to assist with
clinically intelligent diagnostics to improve the quality of patient data and
to help our customers drive productivity and efficiency. The application
focuses on data, organization, workflow and connectivity so physicians can
focus more time on patient care.

"Over the past several years, we have worked closely with our global
customer base through focus groups, user preference and usability testing to
ensure we created a solid foundation for our current and future product
portfolio," said Gijsbert van Kampen, vice president of Global Marketing
Respiratory Diagnostics at CareFusion. "Building on this foundation we
developed SentrySuite to be backwards-compatible with existing databases for
Jaeger and SensorMedics Pulmonary and CardioPulmonary diagnostics devices.
Clinicians can transfer historical patient records to the new platform, and
they can complete patient data comparisons and trend analysis - both of which
are essential for assessing and developing the best patient treatments

Access to the database is provided through a local area network or the
Internet, providing the physician with easy and secure access to patients'

CareFusion has the largest installed base of Pulmonary and
CardioPulmonary Diagnostic equipment, and SentrySuite enables customers to
budget for a phased transition to the new software and hardware environments,
while at the same time updating and extending their laboratories with new

In addition to diagnostic capabilities, the SentrySuite platform offers
many additional benefits, including unlimited user access and user preference
entry screens, animated operator coaching and guidance in real time during
testing, disease classification and one single diagram that captures the
quality of the diagnostics measurement performed on the patient.
SentrySuite's capabilities will expand over time with a wide variety of
diagnostic applications.

SentrySuite is currently available in the United States, Germany,
Austria, Switzerland, the UK, Australia and New Zealand, with growing global

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve
patient care. Born in 2009 as the result of a spin-off from Cardinal Health,
the company is new but its family of products includes some of the most
recognized brands in health care, used in more than 120 countries.

The company develops market-leading technologies including Alaris(R) IV
pumps, Pyxis(R) automated dispensing and patient identification systems,
AirLife(R), AVEA(R) and LTV(TM) series of ventilators and Jaeger(TM) and
SensorMedics(R) respiratory diagnostics products, ChloraPrep(R) skin prep
products, MedMined(TM) services for infection surveillance, V. Mueller(R) and
Snowden-Pencer(R) surgical instruments and NeuroCare diagnostic products.

CareFusion employs more than 15,000 people across its global operations.
More information may be found at

Media International, Annika Hjelm, Switzerland, +41-21-556-3106, annika.hjelm at, or Media U.S., Suzanne Hatcher , +1-858-617-2226, suzanne.hatcher at, or Investors, Carol Cox, +1-858-617-2020, carol.cox at, all of CareFusion

will not be displayed